Answers are grounded in this paper and cite their sources.
Pseudomonas aeruginosa , a frequent pathogen in the intensive care unit (ICU), has the propensity to develop antibiotic resistance. In particular, carbapenem-nonsusceptible (NS) P. aeruginosa poses tremendous challenges, and new antibiotics will be needed to treat this phenotype. Here we determine carbapenem nonsusceptibility rates for contemporary P. aeruginosa isolates from U.S. ICUs and in vitro activities of new β-lactam combination agents.
No takes yet. Share an insight, caveat, or question.
Asempa et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: